ABSTRACT
INTRODUCTION
Expression of the genes for the proα1(I) and proα2(I) chains in type I collagen is coordinately regulated in a variety of physiological and pathological situations (1) . In intact animals and embryos, type I collagen is synthesized by a discrete number of cell types, including osteoblasts, odontoblasts, fibroblasts, mesenchymal cells and smooth muscle cells. It over-accumulates in fibrotic diseases such as lung fibrosis, cirrhosis and scleroderma. In many of these cases it is likely that control of proα1(I) and proα2(I) expression is likely exerted at the transcriptional level, but the precise mechanisms involved during development and in adult tissues are still poorly understood.
In earlier experiments we showed that a -2000 bp promoter of the mouse proα2(I) collagen gene linked to reporter genes was sufficient for tissue-specific expression in transgenic mice and mimicked the pattern of endogenous gene expression during embryonic development. Similarly, a -350 bp promoter, clearly less active than the -2000 bp segment, showed an analogous pattern in transgenic mice, but with practically no osteoblast expression (2) (3) (4) . Our previous studies of the -350 bp promoter identified several functional cis-acting elements (5) and their cognate DNA binding proteins, including a CCAAT binding factor (CBF) binding site between -95 and -75 bp (6) (7) (8) , a CTF/NF1 binding site between -310 and -285 bp (9) and poorly characterized binding sites for unknown factors around -250 and -160 bp (10, 11) . Recent studies identified three short GC-rich segments in the human proα2(I) gene between -323 and -264 bp (12) , whereas other studies presented evidence that a complex of proteins binding in this area participated in the TGF-β response of this promoter (13) .
This study, using deletion analysis, transient expression and in vitro transcription experiments, asked whether additional cis-acting elements were important for the activity of the -350 bp proximal mouse proα2(I) collagen promoter and whether such elements were binding DNA binding proteins.
MATERIALS AND METHODS

Cell culture and DNA transfections
714 Balb 3T3 fibroblasts were cultured in Dulbecco's modified Eagle's medium containing 10% calf serum. Transient transfections were done as described previously (3) except that SVβgal (14) was used as internal control. Briefly, 714 Balb 3T3 fibroblasts were co-transfected with 15 µg luciferase plasmid and 5 µg SVβgal plasmid (15) . The cells were harvested after 48 h. Luciferase levels were measured using D-luciferin (Sigma) as * To whom correspondence should be addressed substrate with a Monolight 2010 Luminometer (Analytical Luminescence Laboratory). β-Galactosidase activity was measured with a resorufin-β-D-galactopyranoside substrate (Boehringer Mannheim) at 30_C.
Reagents
Anti-SP1 antibodies were purchased from Santa Cruz Biotechnology Inc. and the SP1 consensus oligonucleotide from Promega Corp.
DNA constructs
All wild-type and promoter deletion mutants were constructed in plasmid pA3LUC (16) . In pH 6, pH 4 and pH 5, mouse proα2(I) gene sequences -350 to +54 bp, -500 to +54 bp and -2000 to +54 bp respectively were cloned in the HindIII site of the vector. pH39, containing the minimal promoter -40 to +54 bp and 5′-deletion mutants of the -350 to +54 promoter, has been described previously (3) . Internal deletion mutants of the -350 to +54, -500 to +54 and -2000 to +54 promoters were constructed by PCR (17, 18) .
In vitro transcription assay
The assay was performed as described previously (19) . All reactions contained 300 ng plasmid containing proα2(I) promoters and 100 ng control plasmid (pLAG5, RSVLuc or pSV2CAT).
DNase I footprinting
The procedure was as described previously (20) . Ten femtomoles of end-labeled BamHI-NarI fragments of the -350 to +7 proα2(I) promoter were used. Nuclear extracts were prepared according to standard procedures (21) .
Gel retardation assays
One microliter of 714 Balb 3T3 fibroblast nuclear extract (5 µg protein/µl) was incubated with 5 fmol end-labeled double-stranded oligonucleotides in 10 µl at room temperature for 20 min. All binding reactions contained 25 mM HEPES-NaOH, pH 7.9, 10% glycerol, 75 mM KCl, 0.25 mM EDTA, 0.5 mM DTT, 0.5 mM PMSF, 0.05% NP-40 and 1 µg poly(dA·dT). The reactions were electrophoresed on 4-20% gradient polyacrylamide gels (Novex) in 0.5× TBE.
RESULTS
DNase I footprint experiments
Previous transient transfection experiments using a series of 5′-deletion mutants of the -350 bp promoter showed that a substantial decrease in promoter activity occurred between -171 and -133 and also between -108 and -41 (3). To determine whether these active promoter sites interacted with DNA binding proteins, in vitro DNase I footprints of the -350 bp proximal promoter of the mouse proα2(I) collagen gene were performed using nuclear extracts of 714 Balb 3T3 fibroblasts. Three strong DNase I footprints from -176 to -152, from -131 to -114 and from -98 to -75 (a previously identified CBF binding site) were identified (Fig. 1A, lanes 3 and 7, and B, lanes 3 and 7) . This CBF binding site contained a characteristic CCAAT motif from -84 to -80 on the antisense strand. No other CBF binding site was identified. Each of the three protected regions was clearly demonstrated on both DNA strands. Weaker but reproducible footprints were detected between -285 and -258. A protected region around -300, previously identified as a CTF/NF1 binding site, was also detected. The sequences around the CBF binding site, in the segments around -120 and -160 and between -258 and -285, were GC-rich (Fig. 1C ). An excess of the double-stranded -105 to -65 oligonucleotide, containing the CBF binding site, competed both the -98 to -75 and -131 to -114 footprints, suggesting that the GC-rich sequences near the CBF binding site might compete with the -131 to -114 footprint. In contrast, the -105 to -65 oligonucleotide competed with the -176 to -152 footprint only very weakly (Fig. 1A, lane 4, and B, lane 4) . An oligonucleotide containing a consensus SP1 binding site competed with the -131 to -114 footprint and the weaker -285 to -258 footprint, only weakly with the -176 to -152 footprint and almost not at all with the footprint over the CBF binding site (Fig. 1A,  lane 8, and B, lane 8) . Hence, in the -350 bp mouse promoter there are several regions other than the CBF and NF1 binding sites that are binding sites for other proteins. Some DNA binding proteins that bound to the -131 to -114 region also bound to the region of the CBF binding site. Proteins that bound an SP1 consensus site also bound to the -131 to -114 segment, to a lesser extent to the -176 to -152 segment and also to the GC-rich segment near the NF1 binding site.
DNA transfections with internal deletion mutants of the proα2(I) collagen promoter
Several internal deletion mutants were generated. Surprisingly, the promoter activity of a -108 to -40 deletion was as high in transient transfection experiments as the wild-type promoter ( Fig. 2A) . This mutant is missing the CBF binding site and the DNA segment around it, but not the TATA element and the transcription initiation site. In contrast, a point mutation in the CCAAT motif (-84 to -80) significantly decreased promoter activity. Thus, the segment upstream of -108 compensated for the deleted segment. However, when -130 to -40 was deleted, the promoter activity dropped to 14% of the wild-type -350 bp promoter and -108 to -40 deletion mutant activities. Deletion of -170 to -40 reduced promoter activity further to the level obtained with a minimal promoter extending from -40 to +54 (3). Deletion of -220 to -40 also reduced promoter activity to the level obtained with the -170 to -40 deletion. Other internal deletion mutants retained the segment around the CBF binding site but lacked -130 to -110, -170 to -130 or -170 to -110. The first two deletion mutants had 75 and 55% activities respectively, versus the wild-type -350 bp promoter; the third deletion mutant had ∼25% activity. These results indicate that deletion mutants -170 to -110 and -130 to -110 are more active than deletion mutants -170 to -40 and -130 to -40 respectively, hence providing evidence for a role of the -110 to -40 sequence in promoter activity.
The same internal deletions as above were also introduced in promoters containing either 500 or 2000 bp upstream of the transcription start site ( Fig. 2A) . The effect of each was, however, much like that of deletions in the -350 bp promoter, suggesting that the sequences between -2000 and -350 do not compensate for the loss of promoter activity caused by the deletions. In summary, these results suggest that internal deletions of the DNA segments encompassing one of each of the three proximal footprints had a limited effect on promoter activity, consistent with the hypothesis that the two other segments might compensate for these deletions. However, removing both -130 to -40 and -170 to -110 versus removing either -170 to -130, -130 to -110 or -110 to -40 reduced promoter activity much more markedly. Deletion of all three footprints (-170 to -40) almost completely abolished promoter activity.
In vitro transcription of 5′-deletion mutants and internal deletion mutants of the -350 bp promoter
A series of 5′-deletion mutants were tested in in vitro transcription experiments using Balb 3T3 fibroblast nuclear extracts (Fig. 3 ). We observed a marked decrease in promoter activity from -171 to -108 and from -108 to -40, in good agreement with the results of previous transient transfection experiments using the same mutants (3). Both types of experiments suggested that active transcription factors bind between -171 and -108 and to the region bound by CBF.
To obtain additional evidence for the effects caused by the internal promoter deletions in DNA transfection experiments, the same deletion mutants were used in in vitro transcription experiments using Balb 3T3 fibroblast nuclear extracts ( Fig. 4A and B). As in transient expression experiments, the activity of the -108 to -40 deletion mutant (lane 2) was almost as high as that of the wild-type -350 bp promoter (lane 1). In contrast, promoter activity was 3-to 4-fold lower for the mutant with a point 
DNA binding experiments
To obtain additional information about the DNA binding proteins that interact with the -131 to -114 and -176 to -152 segments, gel shift experiments were performed. An oligonucleotide from -140 to -86, including the GC-rich sequences immediately upstream of the CCAAT motif and the -131 to -114 footprint, was used as probe with nuclear extracts of 714 Balb 3T3 fibroblasts. Three prominent DNA-protein complexes were observed (Fig. 5A , lane 1, complexes 1-3), which were completely competed by sequences that included the upstream footprint (-176 to -152), i.e. by oligonucleotide -180 to -136 (lane 5) and by the shorter oligonucleotide -176 to -152 (lane 6). Competition by oligonucleotides -180 to -136 and -176 to -152 at equal molar ratios was clearly stronger than competition by either the probe itself and 11); the Krox oligonucleotide competed for only complex 3 (lanes 9 and 12). The supershift of part of complex 1 produced by anti-SP1 antibodies (see lane 10, complex 4) indicated the presence of SP1. However, compared with the extensive competition by an SP1 consensus oligonucleotide, the SP1 antibodies mainly supershifted only complex 1, with little effect on the other complexes. In summary, several proteins apparently bound the promoter between -140 and -86, including SP1, a protein(s) different from SP1 that bound an SP1 consensus oligonucleotide and a protein(s) that bound to a Krox consensus oligonucleotide. Our competition experiments with two other promoter segments also strongly suggested the existence of redundant binding sites for these proteins.
The same pattern of three major DNA-protein complexes revealed by the -140 to -86 probe was also revealed by the -180 to -136 probe (Fig. 5B) . However, the overall pattern and competition by oligonucleotides were more complex. Oligonucleotides -180 to -136 and -176 to -152 competed for all complexes (lanes 5 and 6) and, at equal molar ratios, much more potently than oligonucleotides -140 to -86 and -135 to -105 (lanes 3 and 4), which failed to compete for the weaker DNA-protein complexes.
The DNase I footprint assay of Figure 1 showed that oligonucleotide -105 to -65, containing the CBF binding site, competed with the footprint between -131 and -114, suggesting that other proteins in addition to CBF could also bind to this segment. When used as probe in gel shift assays (Fig. 5C) , the -105 to -65 oligonucleotide revealed one prominent complex (complex 1) and two minor complexes (complexes 2 and 3, better visualized on lighter exposures of the autoradiograph). A polyclonal antibody to the CBF-A subunit supershifted complexes 1 and 2 (lane 6); the remaining complexes were largely competed for by the SP1 oligonucleotide (lane 7). After supershifting by the CBF-A antibody, complex 3 was also completely competed for by the Krox oligonucleotide (lane 8). A supershifted complex was also detected when anti-SP1 antibodies were used (complex 4, lane 3), a sign that SP1 was present in one of the DNA-protein complexes. These data suggest that in addition to CBF, SP1, proteins binding to an SP1 consensus site and proteins binding to a Krox consensus site also bound to oligonucleotide -105 to -65. These three classes of DNA binding proteins also bound the -180 to -136 and -140 to -86 segments ( Fig. 5A and B) .
Effects of oligonucleotides and SP1 antibodies during in vitro transcription
In vitro transcription experiments were performed in the presence of an excess of oligonucleotides -180 to -136 and the -140 to -86 to compete for binding of proteins interacting with the promoter segments. An excess of oligonucleotide -180 to -136 inhibited transcription of the -350 bp promoter by 70% (Fig. 6A, lane 5 ). An excess of oligonucleotide -140 to -86 decreased transcription by ∼50% (lane 3). This agrees with the relative potency of each of these oligonucleotides in competing for the DNA-protein complexes they form. The SP1 oligonucleotide inhibited transcription by ∼30% (lane 7). It is likely that the -180 to -136 oligonucleotide was able to remove from the template a larger number of transcriptionally active DNA binding proteins than the SP1 oligonucleotide and the -140 to -86 oligonucleotide.
Anti-SP1 antibodies weakly inhibited the wild-type -350 bp promoter (Fig. 6B, lane 1) . However, they more strongly inhibited Table 1. the -108 to -40 deletion mutant promoter (lane 5). In control experiments, the anti-SP1 antibodies completely inhibited the activity of an early SV40 promoter containing repeated SP1 binding sites (lane 3). These experiments indicate that SP1 has a much weaker role in activity of the -350 bp promoter than in the SV40 promoter.
DISCUSSION
Transcriptional control of the type I collagen genes is a complex phenomenon that likely involves both cell-specific and ubiquitous transcription factors. Here, we examined the proximal promoter of the mouse proα2(I) collagen gene for elements critical to transcriptional activation. Our DNase I protection experiments identified three strong footprints in the proximal promoter: -176 to -152, -131 to -114 and -98 to -75. All three segments are GC-rich and the third also contains a CCAAT motif previously shown to bind CBF (6) (7) (8) . The role of each of these three redundant elements in promoter activity was examined by deletion analysis in transient expression experiments and by in vitro transcription experiments. Deleting only the most proximal element had no effect, only the middle element, a relatively small effect and only the most distal element, a more pronounced effect. Deletion of two of the three had a much more pronounced effect, whereas an internal deletion from -170 to -40, removing all three footprints, resulted in very low activity, about the same as for the basal -40 to +54 promoter. Hence, the -170 to -40 segment is essential for activated transcription above the basal level. The results imply that potential transcription elements upstream of -170 cannot activate transcription above the basal level in the absence of -170 to -40. Nonetheless, each of these three proximal elements has an important role in transcription activation. Indeed, deletion of either -170 to -130 or -130 to -110 alone decreased promoter activity. The -130 to -40 deletion mutant had much less activity than the -110 to -40 mutant and the -170 to -40 deletion mutant completely lost its activity. Thus both the -170 to -130 and -130 to -110 regions play important roles in promoter activity. Although the -110 to -40 deletion mutant had essentially full promoter activity in transient transfection and in vitro transcription experiments, this segment itself contains an activating element, since a point mutation in the CCAAT motif that abolished CBF binding caused a 2-to 4-fold decrease in promoter activity in our experiments. Furthermore, the overall enhancing activity of the -110 to -40 element was also indicated by the much higher activity of the -170 to -110 deletion versus the -170 to -40 deletion mutant and of the -130 to -110 deletion mutant versus the -130 to -40 deletion. It may be that removing the -110 to -40 sequence brings the other elements (from -170 to -110) and the transcription factors that bind them closer to the general transcription factors anchored at the TATA box of the promoter, thus providing more efficient interactions between the proteins binding to these upstream sites and the general transcription factors anchored at the TATA box. It may also be that between -110 and -40 lies a repressor binding site whose removal along with the CBF binding site would result in a null effect. A potential inhibitory site has previously been postulated to interact with a putative repressor present in an SV40-transformed cell line but not an untransformed fibroblast line (22) . We favor the former because, as our data indicate, the -110 to -40 element has an overall enhancing activity.
Several classes of proteins present in nuclear extracts bind to segments -180 to -136, -140 to -86 and -105 to -65 (see Fig. 7 for summary). These proteins include SP1, proteins different from SP1 that bind an SP1 consensus binding site and could include other members of the SP1 family, such as SPR2, SPR3 and SPR4 (23) , and proteins that bind to a Krox consensus binding site. All proteins that bind the -140 to -86 segment and all proteins, except CBF, that bind the -105 to -65 segment can also bind the -180 to -136 sequence, however, the latter segment appears to bind additional proteins that show a more complex pattern of DNA binding in gel shift assays. Hence, redundant functionally active DNA elements in the proximal proα2(I) collagen promoter bind several classes of DNA binding proteins. Our mutual competition experiments indicated that proteins that bind the -140 to -86 segment bind with higher efficiency to the -180 to -136 segment. Since many proteins can bind to the redundant DNA GC-rich sequences, site-specific mutagenesis of the binding sites was not helpful in identifying these proteins. Because their precise identification may require cloning their cDNAs, we have recently cloned the cDNAs for two such proteins from a mouse embryo fibroblast cDNA library using the yeast one hybrid system (24) in which the mouse proα2(I) promoter sequence between -180 and -136 was used as bait. One cDNA encoded SPR2, an SP1 family member, while the other encoded a new zinc finger protein (25) .
We further examined the function of the -180 to -136 and -140 to -86 segments during in vitro transcription experiments using oligonucleotide competitors. A 10-fold molar excess of oligonucleotide -180 to -136 reduces transcription activity of the -350 bp promoter by 70%, whereas the same molar excess of oligonucleotide -140 to -86 reduces it by 50%, consistent with the relative ability of these oligonucleotides to mutually compete for DNA binding proteins in DNA binding assays. Competition by an oligonucleotide containing an SP1 consensus binding site inhibited transcription less. Thus either the proteins that bind SP1 consensus sequences do not contribute as much to the activity of the -350 bp promoter as do other proteins, or the transcription factors which bind to the -350 bp promoter interact to form a stable higher order complex that cannot be easily competed for by an oligonucleotide representing an SP1 consensus binding site. Antibodies to SP1 itself had little effect on transcriptional activity of the wild-type -350 bp promoter, but completely inhibited activity of an SV40 promoter, suggesting that SP1 has only a modest role in activity of the proα2(I) promoter. This contrasts sharply with a DNase I footprint experiment showing that recombinant SP1 binds to many sites in the -350 bp promoter (data not shown).
Previously we described the properties of a 3 bp substitution mutation within an 11 bp sequence (-165 and -155) in the proα2(I) promoter (11) . This 11 bp sequence is also found in the proα1(I) proximal promoter. The 3 bp mutation inhibits binding of a DNA binding protein that binds the wild-type sequence. In transient DNA transfection experiments, mutant proα2(I) and proα1(I) promoters containing the same 3 bp mutation showed 4-fold higher activity than the wild-type promoters, suggesting the presence of a negative element. There are at least two possible explanations for the increased activity: (i) the protein that binds the mutant sequence is a bona fide transcriptional repressor; (ii) alternatively, the DNA binding protein is a weak activator and the increase in promoter activity of the mutant promoter is due to binding of a stronger activator to the mutant promoter. Though both proteins could bind to overlapping sites in the wild-type promoter, the mutation would allow better binding of the stronger activator and thus increased activity. We have recently isolated a cDNA for a polypeptide that binds the wild-type sequence but not the above-mentioned substitution mutation. When a segment of this polypeptide was fused to the yeast GAL4 DNA binding domain, it weakly activated transcription in DNA transfection experiments (25) .
There are several functional differences between the human and mouse proximal proα2(I) promoters, despite a high sequence homology (26) . Recent experiments with the human promoter using nuclear extracts of primary human fetal fibroblasts identified two DNase I footprints upstream of -250: one between -330 and -297, the other between -271 and -255 (13) . Evidence was presented for an involvement of both elements in mediating TGF-β activation of the promoter and SP1 was shown to bind to the most upstream of these two elements. Similar segments are also protected against DNase I in the mouse promoter (Fig. 1) . However, whereas NF1 binds to the mouse sequence between -290 and -304 (9), it cannot bind to the equivalent sequence in the human gene, because of sequence differences. Thus NF1 itself is unlikely to be involved in TGF-β activation of this promoter, although the NF1 binding site in the mouse promoter was previously reported to mediate TGF-β activation (27) . Other experiments with the human proα2(I) promoter using nuclear extracts of human foreskin fibroblasts identified a single large footprint between -319 and -267 (12) . This segment contains three GC-rich SP1 binding sequences. These three elements are present at about the same location in the mouse promoter and are protected from DNase I digestion between -285 and -258 ( Fig. 1) , although protection is less pronounced than over the three proximal elements. A 5′ deletion of the human promoter to -264, removing all three GC-rich segments, reduced promoter activity 8-to 10-fold in transient expression experiments. A 5′ deletion in the mouse promoter to -224, however, had practically no effect (12) . This is consistent with the notion that the DNA segment encompassing these three upstream GC-rich sequences may be a stronger promoter element in the human than in the mouse promoter (3, 12, 13) .
In previous experiments the -350 bp mouse promoter showed a low level tissue-specific expression in transgenic mice, reminiscent of the low level tissue-specific expression of the β-globin proximal promoter in the absence of the locus control region (28, 29) . In other experiments we failed, however, to identify both specific sequences in the promoter and specific DNA binding proteins which might account for the tissue specificity of this 350 bp proximal promoter, which exists at very low levels of expression in transgenic mice (4, 30) . Recently we have identified a potent far upstream enhancer located between 13.5 and 17.5 kb upstream of the start of transcription of this promoter which controls expression of reporter genes is mesenchymal cells and fibroblasts (31) .
In summary, this study has established the important role played by three redundant GC-rich segments in the activity of the mouse proα2(I) collagen proximal promoter. Different classes of proteins bind to these sites. We believe that many of these proteins are ubiquitous DNA binding proteins and we are cloning cDNAs for some of these proteins in order to examine their role in activation of this promoter.
